Yifan Pharmaceutical Co., Ltd.

SZSE:002019.SZ

12.27 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001
Omzet 4,022.1573,836.6414,409.0365,400.3815,186.8444,631.7954,373.2943,504.6012,434.931,684.984698.021644.191495.735379.885405.987479.923764.742346.405269.314245.058176.767130.94791.335
Kosten van de omzet 2,191.2681,970.7012,580.6512,890.4662,794.1122,590.2171,870.2951,733.0621,451.4251,012.45501.91497.408386.732280.584270.404278.049275.528224.954188.725164.218121.14687.71254.82
Brutowinst 1,830.8891,865.9391,828.3842,509.9152,392.7312,041.5792,502.9991,771.539983.505672.534196.111146.783109.00299.3135.584201.874489.214121.4580.58980.8455.62143.23536.515
Brutowinstmarge 0.4550.4860.4150.4650.4610.4410.5720.5050.4040.3990.2810.2280.220.2610.3340.4210.640.3510.2990.330.3150.330.4
Onderzoek- en ontwikkelingskosten 406.946190.197196.639325.341208.493167.017141.228105.24740.6620.12816.19218.18640.24126.159000000000
Algemene en administratieve kosten 383.692131.886138.847173.826170.666102.85773.72573.30847.77739.75223.52221.75620.23627.69771.54786.39862.23939.80527.41629.6216.30112.3926.242
Verkoop- en marketingkosten 1,119.1481,040.992892.627703.369628.195552.508437.638428.023368.45258.70734.38229.05125.9520.3420.2336.58543.14153.79113.2199.5776.0713.5633.091
Verkoop-, algemene en administratieve kosten 1,498.3891,172.8781,031.474877.194798.86655.364511.364501.33416.227298.45957.90450.80746.18648.03791.776122.983105.37993.59640.63539.19722.37215.9559.332
Overige kosten 841.45161.892248.187133.059190.574-8.27423.7868.74371.9972.6492.96916.5911.9232.8366.5461.017-1.3260.4660.8130.8073.0315.1810.045
Bedrijfskosten 2,811.7081,524.9661,476.2991,335.5941,197.9281,052.052839.431796.087575.037366.617131.205126.058139.157122.24695.382128.087116.52796.743.19240.58123.28416.6149.768
Bedrijfsresultaat -882.712399.375348.5611,084.5561,076.041891.1231,506.444899.458377.199299.29225.344-3.209-230.121-186.88530.05555.597350.2587.36826.15239.92129.524.97925.671
Bedrijfsresultaat ratio -0.2190.1040.0790.2010.2070.1920.3440.2570.1550.1780.036-0.005-0.464-0.4920.0740.1160.4580.0210.0970.1630.1670.1910.281
Totaal overige inkomsten en kosten netto 13.68112.929-137.772-3.844-7.853-6.21123.786-4.81267.1352.1221.64215.759-193.951-166.584-2.317-24.919-23.951-15.177-13.06-1.952.3764.889-0.345
Inkomen voor belasting -869.031156.737210.7891,080.7131,068.188884.9121,530.23894.646444.334301.41427.05711.837-236.174-194.6535.24148.867348.7366.51125.65139.51931.87629.86925.326
Inkomen voor belasting ratio -0.2160.0410.0480.20.2060.1910.350.2550.1820.1790.0390.018-0.476-0.5120.0870.1020.4560.0190.0950.1610.180.2280.277
Belastingkosten 16.61929.583-31.425149.319195.072191.236264.572211.2582.37363.4761.4480.5180.666.8594.8717.63108.5464.5665.147.0035.9983.8020.605
Nettowinst -551.073127.154278.399968.391903.468737.4371,305.104704.763360.573237.90925.60914.319-230.291-197.55230.3741.237240.1891.93720.48132.51625.87826.06724.721
Nettowinstmarge -0.1370.0330.0630.1790.1740.1590.2980.2010.1480.1410.0370.022-0.465-0.520.0750.0860.3140.0060.0760.1330.1460.1990.271
WPA (Winst Per Aandeel) -0.450.110.230.80.750.611.150.640.330.350.220.026-0.42-0.360.060.0880.50.020.0430.0470.0520.0530.086
Verwaterde WPA -0.450.10.230.790.740.611.150.640.330.350.220.026-0.42-0.360.060.0880.50.020.0430.0470.0520.0530.086
EBITDA -483.525471.013492.5511,342.5711,306.571,068.2691,704.2041,036.772541.866327.803117.61896.62-159.384-135.81478.555106.581397.93754.97764.464.46649.76931.64226.972
EBITDA ratio -0.120.1640.1260.2510.270.2480.4050.3160.2380.1980.1690.2130.0150.040.2010.2540.5260.1410.2390.2630.2820.2420.295